0
Genomics Data Security Act
2/16/2024, 9:08 PM
Summary of Bill S 289
Genomic data, which includes information about an individual's genetic makeup, is becoming increasingly important in the fields of healthcare, research, and personalized medicine. However, there are growing concerns about the security of this data and the potential for it to be misused or accessed without consent.
The Genomics Data Security Act aims to establish guidelines and regulations for the secure collection, storage, and sharing of genomic data. This includes requirements for encryption, access controls, and data breach notification procedures. The bill also seeks to ensure that individuals have control over their own genomic data and are able to consent to how it is used. Overall, the Genomics Data Security Act is designed to protect the privacy and security of genomic data while still allowing for its important use in research and healthcare. It is an important piece of legislation that addresses a growing need for regulation in this rapidly advancing field.
Congressional Summary of S 289
Genomics Data Security Act
This bill establishes requirements and otherwise directs the National Institutes of Health (NIH) to take actions to address national security concerns in genomic and other research.
Specifically, the bill prohibits the use of NIH funds by any Chinese company (or its subcontractors or subsidiaries). This includes companies (1) over which the Chinese government, a Chinese national, or an entity organized under Chinese law exercises control; or (2) in which the Chinese government has a substantial interest. It also requires, as a condition of certification, that clinical laboratories that have access to U.S. health data disclose ties to the Chinese government.
In addition, the NIH must incorporate national security issues in its strategic plan and report annually on any improperly disclosed, vetted, or approved ties that NIH-funded researchers have to foreign governments.
Furthermore, the Department of Health and Human Services must establish a working group to update the NIH's Genomic Data Sharing Policy with respect to intellectual property, national security, and privacy concerns.
